Imunon, Inc. SEC filings IMNN
Imunon, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jun 13, 2011. Its latest annual report, Form ARS, was filed on May 4, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | May 4, 2026 | May 4, 2026 |
| DEF 14A | Proxy statement | Jun 9, 2025 | Jun 9, 2025 |
| PRE 14A | Preliminary proxy statement | May 30, 2025 | May 30, 2025 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Apr 28, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Apr 28, 2022 |
| DEFA14A | Additional proxy material | Jan 26, 2022 | — |
| DEF 14A | Proxy statement | Jan 25, 2022 | Jan 25, 2022 |
| PRE 14A | Preliminary proxy statement | Jan 14, 2022 | Jan 14, 2022 |
| DEFA14A | Additional proxy material | Jun 7, 2021 | — |
| DEFA14A | Additional proxy material | Jun 4, 2021 | — |
| DEFA14A | Additional proxy material | May 27, 2021 | — |
| DEF 14A | Proxy statement | Apr 20, 2021 | Apr 20, 2021 |
| PRE 14A | Preliminary proxy statement | Apr 8, 2021 | Apr 8, 2021 |
| DEF 14A | Proxy statement | Apr 29, 2020 | Apr 29, 2020 |
| DEF 14A | Proxy statement | Mar 29, 2019 | Mar 29, 2019 |
| DEF 14A | Proxy statement | Mar 30, 2018 | May 15, 2018 |
| DEF 14A | Proxy statement | Apr 4, 2017 | May 16, 2017 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2017 | May 16, 2017 |
| DEF 14A | Proxy statement | May 5, 2016 | Jun 15, 2016 |
| PRE 14A | Preliminary proxy statement | Apr 25, 2016 | Jun 15, 2016 |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 19, 2015 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2015 | Jun 19, 2015 |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jun 20, 2014 |
| DEF 14A | Proxy statement | Jun 7, 2013 | Jul 19, 2013 |
| PRE 14A | Preliminary proxy statement | May 17, 2013 | Jul 19, 2013 |
| DEF 14A | Proxy statement | Apr 27, 2012 | Jun 7, 2012 |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMNN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lawrenceville, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 749647
- Former names
- CELSION CORP (until Sep 19, 2022); Celsion CORP (until Sep 19, 2022); CHEUNG LABORATORIES INC (until Feb 17, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.